I'm not too concerned about vultures. Management have deliberately separated the business into 2 segments:
1. Glaucoma (iTrack)
2. AMD (AlphaRet) - from memory this is a complete separate entity which they created a couple of years ago
The 2RT partnership is for AlphaRet only.
iTrack, we know comparable transactions in this space, so management cannot accept anything not close to the comparables.
Nova Eye Medical (EYE) Discussion, page-689
-
- There are more pages in this discussion • 2,499 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65104 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 51773 | 2 |
View Market Depth
| Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |